Yüklüyor......
Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor–positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.
Kaydedildi:
| Yayımlandı: | J Adv Pract Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Harborside Press LLC
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857322/ https://ncbi.nlm.nih.gov/pubmed/33598325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2020.11.3.12 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|